Showing all 95 results
Adefovir Dipivoxil Tablets
FreeProduct Composition & Strengths
We supply this therapeutic in the globally accepted standard therapeutic strength optimized for adult daily maintenance therapy.
Active Ingredient Standard Strength Primary Clinical Target Adefovir Dipivoxil IP / BP / USP 10 mg The Polymerase Blocker: Daily oral dose to suppress chronic Hepatitis B viral loads. Excipients Pharma Grade The Matrix: High-stability lactose/microcrystalline cellulose binders. Amiodarone Tablet
FreeProduct Composition & Available Strengths
We manufacture Amiodarone in standard, internationally recognized strengths to allow for the intensive loading phase and lower maintenance doses required in cardiology.
Active Ingredient Standard Strengths Primary Clinical Target Amiodarone HCl BP / IP / USP 100 mg Low-Dose Maintenance: For fine-tuned long-term rhythm control and geriatric titration. Amiodarone HCl BP / IP / USP 200 mg Standard Therapy: Used for initial institutional oral loading phases and standard daily maintenance. Amlodipine & Enalapril Maleate Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets to protect the Enalapril Maleate from moisture-induced degradation and to ensure the physical integrity of the combination.
Active Ingredient Strength (Standard) Therapeutic Role Amlodipine (as Besylate) BP/USP 5 mg / 10 mg Calcium Channel Blocker (CCB) Enalapril Maleate BP/USP 5 mg / 10 mg / 20 mg ACE Inhibitor Excipients Q.S. Sodium Stearyl Fumarate / Lactose Lubricant & Stabilizer Amlodipine Besylate & Losartan Potassium Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The formulation is optimized for 24-hour efficacy, allowing for convenient once-daily dosing.
Active Ingredient Strength (Standard) Therapeutic Role Amlodipine Besylate BP/USP 5 mg Calcium Channel Blocker (CCB) Losartan Potassium BP/USP 50 mg Angiotensin Receptor Blocker (ARB) Excipients Q.S. Microcrystalline Cellulose / Starch Stabilizing Core Matrix Amlodipine With Lisinopril Dehydrate Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. The use of Lisinopril in its Dihydrate form ensures superior stability and predictable dissolution profiles.
Active Ingredient Strength (Standard) Therapeutic Role Amlodipine (as Besylate) BP/USP 5 mg / 10 mg Calcium Channel Blocker Lisinopril (as Dihydrate) BP/USP 5 mg / 10 mg / 20 mg ACE Inhibitor Excipients Q.S. Calcium Phosphate / Mannitol Stabilizing Agents Antacid & Anti-Ulcerant Tablets
FreeTechnical & Logistics Specifications
Parameter Specifications & Standards HS Code 3004.90.99 (Medicaments acting on the alimentary tract and metabolism) Pharmacopeia Compliance IP / BP / USP / EP Dosage Formats Enteric-Coated, Delayed-Release, Film-Coated, and Chewable Tablets Export Packaging 10 / 14 / 15 Tablets per Blister packed exclusively in high-barrier Alu-Alu (Cold-Form Foil) or thick PVC/PVDC matrixes to protect against moisture ingress in Zone IVb tropical climates. Shelf-Life Stability Fully validated 36-Month real-time stability metrics Artesunate & Amodiaquine Tablets
FreeProduct Composition & Available Strengths
We supply this product in both modern co-formulated Fixed-Dose Combination (FDC) single tablets and customized co-blistered kits, accurately titrated for adult and pediatric compliance.
Formulation Format Active Ingredient Mix (per Dose) Target Patient Segment Primary Clinical Function Infant / Pediatric FDC 25 mg Artesunate + 67.5 mg Amodiaquine Infants (2 months to less than 1 year) Early Intervention: Specially sized for pediatric dispersal. Toddler / Child FDC 50 mg Artesunate + 135 mg Amodiaquine Children (1 year to less than 6 years) Growth Tier: Optimized for easy pediatric administration. Youth / Adolescent FDC 100 mg Artesunate + 270 mg Amodiaquine Adolescents (6 years to less than 14 years) Intermediate Tier: Ensures accurate dosing for older children. Adult Potency FDC 100 mg + 270 mg (2 Tablets/Day) or 200 mg + 540 mg Adults & Children over 14 years Full Strength: Complete 3-day treatment matrix. Artesunate & Mefloquine Tablet
FreeProduct Composition & Compliance Configurations
We supply this combination in both co-formulated Fixed-Dose Combination (FDC) single tablets and customized, color-coded co-blistered kits calibrated for adult and pediatric treatment regimens.
Product Packaging Format Active Ingredient Mix (per Dose) Target Patient Cohort Primary Clinical Function Pediatric Compliance FDC 25 mg Artesunate + 55 mg Mefloquine Infants & Children (6 months to less than 7 years) Micro-Dose Accuracy: Optimized for easy pediatric disintegration and ingestion. Adolescent Strength FDC 100 mg Artesunate + 220 mg Mefloquine Youth & Teenagers (7 years to less than 14 years) Intermediate Titration: Ensures balanced dosing without neuro-toxicity risks. Adult Potency FDC / Kit 100 mg + 220 mg (2 Tablets/Day for 3 days) or 200 mg + 440 mg Adults & Children over 14 years Full Strength Treatment: Maximizes biomass eradication in multi-drug resistant zones. Artesunate & Sulphadoxine-Pyrimethamine Tablets
FreeProduct Composition & Kit Configuration
We supply this product in standardized, age-titrated Fixed-Dose Combination (FDC) Blister Strips, commonly containing a 3-day course of Artesunate tablets alongside a single-dose treatment of Sulfadoxine-Pyrimethamine.
Component Tablet Type Active Ingredient Mix Standard Strengths (per Tablet) Primary Clinical Function Artesunate Tablet Artesunate 50 mg / 100 mg / 200 mg The Fast Cleaver: Clears parasite biomass over 3 consecutive days. Sulfadoxine-Pyrimethamine Tablet Sulfadoxine + Pyrimethamine 500 mg + 25 mg The Extended Shield: Single-dose companion to prevent recrudescence. Atenolol & Chlorthalidone Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The combination is engineered to maintain therapeutic plasma levels over a 24-hour period, supporting once-daily dosing.
Active Ingredient Strength (Standard) Therapeutic Role Atenolol BP/USP 50 mg / 100 mg Cardioselective Beta-Blocker Chlorthalidone BP/USP 12.5 mg / 25 mg Long-acting Diuretic Excipients Q.S. Magnesium Stearate / Povidone Stabilizing Core Matrix Calcium Carbonate & Vitamin D3 Tablets
FreeProduct Composition & Common Strengths
We supply this combination in standard, clinically calibrated ratios designed to optimize daily absorption thresholds without overwhelming intestinal transit.
Active Ingredient Components Standard Strengths (per Tablet) Elemental Yield / Biological Activity Primary Clinical Function Calcium Carbonate IP / BP / USP 1250 mg Yields 500 mg Elemental Calcium The Scaffold: Provides the physical structural block for bone density. Vitamin D3 (Cholecalciferol) IP/BP/USP 250 IU / 400 IU Equivalent to 6.25 mcg / 10.0 mcg The Catalyst: Chemically drives intestinal transport channels. Excipients Pharma Grade Modified Matrix Adjusters The Carrier: Ensures fast disintegration or chewable palatability. Carbimazole Tablets
FreeProduct Composition & Available Strengths
We manufacture Carbimazole in exact, internationally recognized strengths to facilitate precise dosage titration based on periodic patient blood chemistry.
Active Ingredient Standard Strengths Primary Clinical Target Carbimazole BP/IP/USP 5 mg Maintenance Titration: For long-term control once stable thyroid levels are chemically achieved. Carbimazole BP/IP/USP 10 mg Initial Suppression: High-dose intervention to rapidly bring down severely elevated $T_{3}$/$T_{4}$ levels. Chlorpheniramine Tablets
FreeProduct Composition & Strength
We supply this product in the globally accepted standard strength for adult dosing, ensuring safe and effective treatment cycles.
Active Ingredient Strength (per Tablet) Primary Clinical Function Chlorpheniramine Maleate IP/BP/USP 4 mg The H1 Blocker: Rapidly controls acute allergic flares. Excipients Pharma Grade The Matrix: Ensures shelf-life stability and rapid dissolution. Chlorpromazine Tablets
FreeProduct Composition & Available Strengths
We provide this therapeutic in a versatile range of strengths to allow for the precise dose titration required in specialized psychiatric medicine.
Active Ingredient Standard Strengths Primary Clinical Target Chlorpromazine HCl IP/BP/USP 25 mg Low-Dose Titration: For anxiety, pediatric hiccups, or elderly care. Chlorpromazine HCl IP/BP/USP 50 mg Maintenance Therapy: For stable outpatient management of schizophrenia. Chlorpromazine HCl IP/BP/USP 100 mg Acute Crisis Control: High-potency dosing for acute manic or psychotic states. Chymotrypsin Tablets
FreeProduct Composition & Enzyme Potency
We supply this product as a synergistic Trypsin-Chymotrypsin Fixed-Dose Combination (FDC), calibrated in Armour Units (AU) for maximum biological activity.
Active Ingredient Mixture Enzyme Ratio Standard Potency Options Primary Clinical Function Trypsin & Chymotrypsin IP/BP/USP 6:1 50,000 Armour Units (AU) Maintenance Recovery: For standard soft-tissue trauma and mild post-operative edema. Trypsin & Chymotrypsin IP/BP/USP 6:1 100,000 Armour Units (AU) High-Intensity Therapy: For major orthopedic adjustments, dental extractions, and large hematomas. Cinnarizine Tablets
FreeTechnical & Manufacturing Specifications
Formulated for consistent release kinetics and long-term chemical stability.
Technical Metric Specification Standard Active Ingredient Cinnarizine BP / USP / IP Dosage Form Immediate Release Tablets Available Strengths 25 mg (Vestibular) / 75 mg (Cerebrovascular) HS Code 3004.90.39 (Other CNS drugs) / 2933.59.90 Stability Validated for Zone IVb (Tropical) export markets Clonazepam Tablets
FreeProduct Composition & Available Strengths
We supply Clonazepam across the complete, internationally standardized therapeutic spectrum to facilitate precise titration for both pediatric epilepsy and high-potency adult neurological control.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Clonazepam USP / BP / IP 0.5 mg
(500 mcg)
Oral / Sublingual Micro-Tablet Epilepsy Titration / Panic Baseline: For pediatric seizure disorders, low-dose stabilization, and initial panic management. Clonazepam USP / BP / IP 1.0 mg
(1000 mcg)
Oral / Sublingual Micro-Tablet Intermediate Maintenance: Step-up strength optimized for routine daily neurological maintenance without expanding tablet counts. Clonazepam USP / BP / IP 2.0 mg
(2000 mcg)
Oral High-Potency Solid Tablet Refractory Epilepsy & Acute Care: High-strength configuration calibrated for status epilepticus prophylaxis, myoclonic spasms, and manic stabilization. Clozapine Tablets
FreeProduct Composition & Available Titration Strengths
Because Clozapine demands highly delicate, low-dose initial titration to protect the patient’s cardiovascular profile, we manufacture the full compendial strength spectrum.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Clozapine USP / BP / IP 25 mg Oral Solid Uncoated Micro-Tablet Introductory Safety Titration: Mandatory low-dose baseline format utilized exclusively for the initial day 1 and day 2 dose-escalation phase to prevent orthostatic shock. Clozapine USP / BP / IP 50 mg Oral Solid Uncoated Micro-Tablet Intermediate Dose Step-Up: Mid-tier titration strength engineered to scale up systemic tolerance during weeks 1 and 2. Clozapine USP / BP / IP 100 mg Oral Solid Compressed Tablet The Core Commercial Volume: First-line international standard target maintenance strength for adult refractory schizophrenia management. Co -Trimoxazole Tablets Tablet
FreeCo- Trimoxazole Tablets IP
Trimethoprime & Sulphamethoxazole Tablets IP
Each Uncoated tablet contains :
Trimethoprime IP 20 mg
Sulphamethoxazole IP 100 mgTrimethoprim & sulphamethoxazole tablets IP Co -trimoxazole Tablets IP
Each film coated tablets : Excipients q.s
Trimethoprim IP 80 mg
Sulphamethoxazole IP 400 mgTrimethoprim & sulphamethoxazole tablets IP
Each film coated tablets :
Trimethoprim IP 160 mg
Sulphamethoxazole IP 800 mgCo – Trimoxazole Tablets BP
Trimethoprim & Sulphamethoxazole Tablets BP
Each Uncoated Tablet contains :
Trimethoprim BP 80 mg
Sulfamethoxazole BP 400 mgTACOT – DS
Trimethoprim & Sulphamethoxazole Tablets BP
Each Uncoated tablet contains :
Trimethoprim BP 160 mg
Sulphamethoxazole BP 800 mgUsage: – Traveler’s diarrhea
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Ferrous Fumarate with Folic Acid Tablet
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The coating is essential to mask the metallic taste of iron and prevent the oxidation of the ferrous salt during storage.
Active Ingredient Strength (Standard) Therapeutic Role Ferrous Fumarate BP/USP 200 mg / 300 mg Hematinic (Iron Supplement) Folic Acid BP/USP 0.4 mg / 0.5 mg / 1 mg / 5 mg Vitamin B9 (Folates) Excipients Q.S. Povidone / Talc / Magnesium Stearate Stabilizing Core Matrix Glibenclamide & Metformin Hydrochloride Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) designed for flexible clinical titration.
Active Ingredient Standard Strengths (per Tablet) Primary Clinical Function Metformin HCl 400 mg / 500 mg The Foundation: Reduces glucose production. Glibenclamide (Glyburide) 2.5 mg / 5 mg The Stimulator: Enhances insulin secretion. Excipients Pharma Grade The Matrix: Ensures stability of the FDC. Hyoscine Butylbromide Tablets
FreeProduct Composition & Strength
We supply this product as Sugar Coated Tablets or Film Coated Tablets. The coating is essential to mask the naturally bitter taste of the active ingredient and ensure patient compliance.
Active Ingredient Strength (Standard) Therapeutic Role Hyoscine Butylbromide BP/USP 10 mg Muscarinic Antagonist (Antispasmodic) Excipients Q.S. Calcium Hydrogen Phosphate / Maize Starch Stabilizing Core Matrix Coating Agent Q.S. Sucrose / Talc / Acacia Traditional Sugar Coating Isoniazid & Pyridoxine Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. The ratio of Isoniazid to Pyridoxine is carefully calibrated to meet international clinical guidelines for neuroprotection.
Active Ingredient Strength (Standard) Therapeutic Role Isoniazid BP/USP 300 mg Primary Antitubercular (Bactericidal) Pyridoxine Hydrochloride BP/USP 10 mg / 25 mg / 50 mg Neuroprotective Vitamin (B6) Excipients Q.S. Starch / Lactose / Magnesium Stearate Tablet Core Matrix Isoniazid & Pyridoxine Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. The ratio of Isoniazid to Pyridoxine is carefully calibrated to meet international clinical guidelines for neuroprotection.
Active Ingredient Strength (Standard) Therapeutic Role Isoniazid BP/USP 300 mg Primary Antitubercular (Bactericidal) Pyridoxine Hydrochloride BP/USP 10 mg / 25 mg / 50 mg Neuroprotective Vitamin (B6) Excipients Q.S. Starch / Lactose / Magnesium Stearate Tablet Core Matrix Isosorbide Mononitrate Tablets
FreeProduct Composition & Strength
We supply this product as Immediate Release Tablets (20 mg). We also offer Extended Release (ER/SR) variants for once-daily dosing through our contract manufacturing division.
Active Ingredient Strength (Standard) Therapeutic Role Isosorbide Mononitrate BP/USP 20 mg Organic Nitrate / Vasodilator Excipients Q.S. Microcrystalline Cellulose / Lactose Stabilizing Matrix Isosorbide Tablets
FreeProduct Composition & Variants
We supply both Mononitrate and Dinitrate forms in immediate and sustained-release formats.
Variant Type Standard Strengths Primary Clinical Use Isosorbide Mononitrate 10mg, 20mg, 40mg Prophylaxis: Long-term prevention of angina. Isosorbide Dinitrate 5mg, 10mg, 20mg Acute & Chronic: Short and long-term heart failure. Sustained Release (SR) 30mg, 60mg Once-Daily: For improved patient compliance. Lamivudine Tablets
FreeProduct Composition & Available Portfolio strengths
We manufacture Lamivudine across the precise compendial strengths mandated to manage either targeted chronic hepatic monotherapy or high-potency systemic combination antiretroviral protocols.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamivudine USP / BP / IP 100 mg Oral Solid Film-Coated Tablet Chronic Hepatitis B (HBV): Low-dose configuration optimized for standalone daily suppression of active hepatic viral replication. Lamivudine USP / BP / IP 150 mg Oral Solid Film-Coated Tablet Standard Antiretroviral (HIV): Baseline strength designed for twice-daily co-administration or integration into standard multi-drug ARV regimens. Lamivudine USP / BP / IP 300 mg Oral High-Potency Solid Tablet High-Compliance Antiretroviral (HIV): Standard adult once-daily high-dose format engineered to optimize long-term patient compliance. Lamotrigine Tablets
FreeProduct Composition & Available Strengths
Because Lamotrigine demands highly delicate, low-dose introductory titration to ensure patient dermatological safety, we manufacture the full compendial strength matrix.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamotrigine USP / BP / IP 25 mg Oral Solid Uncoated / Dispersible Tablet Dermatological Intro Titration: Mandatory low-dose baseline format utilized exclusively for the critical initial 2-week dose-escalation phase. Lamotrigine USP / BP / IP 50 mg Oral Solid Uncoated / Dispersible Tablet Intermediate Step-Up Dosing: Step-up strength calibrated for weeks 3 and 4 of therapy to safely approach steady-state plasma metrics. Lamotrigine USP / BP / IP 100 mg Oral Solid Compressed Tablet Standard Maintenance Block: First-line international standard strength for adult maintenance monotherapy in epilepsy and bipolar stabilization. Lamotrigine USP / BP / IP 200 mg Oral High-Potency Solid Tablet Maximal Saturation Maintenance: High-strength configuration calibrated for advanced refractory partial seizures and combination therapies. Leflunomide Tablets
FreeProduct Composition & Available Portfolio Strengths
We supply Leflunomide across the complete compendial strength matrix, enabling clinicians to manage both rapid initial loading cycles and long-term low-dose maintenance blocks.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Leflunomide USP / BP / IP 10 mg Oral Solid Film-Coated Tablet Low-Dose Maintenance: Calibrated for mild-to-moderate maintenance blocks or patients exhibiting sensitive hepatic profiles. Leflunomide USP / BP / IP 20 mg Oral Solid Film-Coated Tablet The Core Commercial Volume: First-line international standard daily maintenance dose for active Rheumatoid and Psoriatic Arthritis. Leflunomide USP / BP / IP 100 mg Oral High-Mass Solid Tablet Initial Loading Regimen: High-potency format utilized exclusively for the rapid 3-day initial tissue saturation phase. Levamisole Hydrochloride veterinary injection
FreeComposition
Levamisole Hydrochloride INJ. 30ML
Usage: – It is typically administered as an injectable solution or added to the animal’s feed.
Category: – parasitic infections veterinary injection
Therapeutic category: –parasitic infections veterinary injection
Levamisole Tablets
FreeProduct Composition & Available Strengths
We supply Levamisole Hydrochloride across the two primary compendial configurations required to execute precise pediatric deworming courses or adult high-mass therapeutic maintenance.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Levamisole Hydrochloride USP / BP / IP 50 mg Oral Solid Uncoated / Chewable Tablet Pediatric Deworming & Titration: Low-dose format calibrated for exact mass titration in pediatric ascariasis or low-dose immunomodulatory courses. Levamisole Hydrochloride USP / BP / IP 150 mg Oral Solid Compressed Tablet The Core Commercial Volume: High-potency, single-dose adult baseline format optimized for rapid mass community deworming campaigns. Levocetirizine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The small, easy-to-swallow tablets are engineered for rapid disintegration to facilitate quick relief from acute allergic flares.
Active Ingredient Strength (Standard) Therapeutic Role Levocetirizine Dihydrochloride BP/USP 5 mg Potent H1-Receptor Antagonist Excipients Q.S. Microcrystalline Cellulose / Lactose Diluent & Disintegrant Coating Agent Q.S. Opadry® White Protective Film Coating Levofloxacin Tablets
FreeProduct Composition & Available Portfolio
We manufacture Levofloxacin across the complete, internationally standardized therapeutic spectrum to accommodate customized tissue-saturation requirements and specific treatment durations.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 250 mg Oral Solid Film-Coated Tablet Uncomplicated Infections: For standard low-dose management of uncomplicated urinary tract infections (UTIs) and acute bacterial sinusitis. Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 500 mg Oral Solid Film-Coated Tablet The Core Commercial Volume: First-line international standard for community-acquired pneumonia (CAP), skin structures, and acute pyelonephritis. Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 750 mg Oral High-Potency Solid Tablet Intensive High-Dose Short-Course: Calibrated for nosocomial pneumonia, complicated skin infections, and advanced multi-drug resistant (MDR) regimens. Levothyroxine Tablet
FreeProduct Composition & Comprehensive Portfolio Range
Because thyroid replacement demands hyper-specific, patient-tailored titrations, we manufacture the entire internationally recognized microgram ($\mu\text{g}$) matrix.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Levothyroxine Sodium USP / BP / IP 25 mcg / 50 mcg Oral Solid Uncoated Micro-Tablet Pediatric & Geriatric Initialization: For delicate low-dose titration in elderly cardiac profiles or initial pediatric replacement. Levothyroxine Sodium USP / BP / IP 75 mcg / 88 mcg / 100 mcg Oral Solid Uncoated Micro-Tablet The Core Commercial Volume: Standard adult maintenance strengths for matching routine daily baseline metabolic deficiencies. Levothyroxine Sodium USP / BP / IP 112 mcg / 125 mcg / 137 mcg Oral Solid Uncoated Micro-Tablet Precision Step-Up Adjustments: Calibrated strengths engineered to adjust plasma levels without requiring multiple or split tablets. Levothyroxine Sodium USP / BP / IP 150 mcg / 175 mcg / 200 mcg Oral High-Potency Micro-Tablet Advanced Suppression Maintenance: For severe profound hypothyroidism, total thyroidectomy recovery, and thyroid cancer suppression therapy. Lisinopril Tablet
FreeProduct Composition & Available Portfolio Range
We manufacture Lisinopril in exact, compendial strengths calibrated to support initial introductory titration up to high-potency cardioprotective maintenance blocks.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lisinopril Anhydrous / Dihydrate USP / BP / IP 5 mg Oral Solid Uncoated Tablet Initial Titration: For low-dose introductory management, pediatric hypertension, or initial combination therapy initiation. Lisinopril Anhydrous / Dihydrate USP / BP / IP 10 mg Oral Solid Uncoated Tablet Core Commercial Volume: Standard international baseline daily dose for mild-to-moderate chronic essential hypertension. Lisinopril Anhydrous / Dihydrate USP / BP / IP 20 mg Oral High-Potency Solid Tablet Advanced Cardioprotection: High-strength configuration calibrated for severe heart failure management and post-infarction survival optimization. Loperamide Tablet
FreeProduct Composition & Configuration
We supply Loperamide Hydrochloride in the internationally standardized 2 mg therapeutic dosage configuration, engineered for rapid disintegration and fast symptomatic relief.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Loperamide Hydrochloride USP / BP / IP 2 mg Oral Solid Immediate-Release Uncoated Tablet Fast-Acting Anti-Diarrheal: Non-specific acute diarrhea management, chronic diarrheal stabilization, and ileostomy output reduction. Excipients Pharma Grade Lactose Monohydrate, Microcrystalline Cellulose, Corn Starch, Magnesium Stearate The Disintegration Scaffold: Optimized matrix for high mechanical stability and rapid water wicking. Loratidine Tablet
FreeProduct Composition & Available Strengths
We supply Loratadine in the internationally recognized 10 mg therapeutic dosage configuration, optimized for maximum daily compliance and clean absorption kinetics.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Loratadine USP / BP / IP 10 mg Oral Solid Immediate-Release Uncoated Tablet 24-Hour Allergy Control: Treatment of allergic rhinitis (hay fever), chronic idiopathic urticaria (hives), and ocular allergic reactions. Excipients Pharma Grade Lactose Monohydrate, Corn Starch, Magnesium Stearate The Disintegration Scaffold: Optimized matrix for high mechanical stability during bulk shipping and rapid water-wicking in the gut. Lorazepam Tablet
FreeProduct Composition & Available Strengths
We supply Lorazepam across the complete, internationally standardized therapeutic spectrum to allow for safe dose titration and exact behavioral control.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Target Lorazepam USP / BP / IP 0.5 mg Oral / Sublingual Micro-Tablet Mild Anxiety & Pediatric Titration: For delicate introductory dosing and generalized anxiety management. Lorazepam USP / BP / IP 1.0 mg Oral / Sublingual Micro-Tablet Foundation Anxiolytic / Insomnia: Standard baseline dosage for acute panic control and pre-operative sedation. Lorazepam USP / BP / IP 2.0 mg Oral High-Potency Solid Tablet Critical Care Stabilization: For intensive management of acute manic states, alcohol withdrawal delirium, and status epilepticus. Losartan Tablet
FreeProduct Composition & Available Strengths
We supply Losartan Potassium across the complete, internationally recognized therapeutic range to facilitate progressive dose titrations and precise maintenance regimens.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Losartan Potassium USP / BP / IP 25 mg Oral Solid Film-Coated Tablet Pediatric & Low-Dose Titration: For introductory pediatric hypertension care or initial combination-therapy building. Losartan Potassium USP / BP / IP 50 mg Oral Solid Film-Coated Tablet Core Commercial Volume: Standard international baseline daily dose for mild-to-moderate chronic essential hypertension. Losartan Potassium USP / BP / IP 100 mg Oral High-Potency Solid Tablet Maximal Saturation Maintenance: For advanced hypertensive management, diabetic nephropathy progression delay, and stroke risk reduction in left ventricular hypertrophy. Mebendazole Tablet
FreeProduct Composition & Available Formats
We supply Mebendazole across the two primary compendial configurations required to execute either targeted individual eradication or high-velocity single-dose mass eradication protocols.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Mebendazole USP / BP / IP 100 mg Oral Solid Chewable / Dispersible Tablet Targeted Multi-Dose Therapy: Standard baseline format for individual 3-day courses targeting specific multi-worm infestations (Pinworms, Roundworms, Hookworms). Mebendazole USP / BP / IP 500 mg High-Mass Oral Solid Single-Dose Tablet Mass Public Health Eradication: High-potency, single-dose format engineered for rapid deployment in mass community deworming campaigns. Mebeverine Tablet
FreeProduct Composition & Available Formats
We supply Mebeverine Hydrochloride in both rapid-acting immediate-release and advanced continuous-release configurations to accommodate customized patient compliance tracking.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Mebeverine Hydrochloride IP / BP / USP 135 mg Oral Solid Immediate-Release Film-Coated Tablet Targeted Acute Dosing: Fast-acting formulation designed for standard three-times-daily administration prior to localized food triggers. Mebeverine Hydrochloride IP / BP / USP 200 mg SR Sustained-Release Hydrophilic Polymer Matrix Tablet / Capsule Continuous 24-Hour Coverage: Premium, once- or twice-daily formulation engineered to release active molecules continuously, eliminating nocturnal spikes and maximizing compliance. Mefenamic Tablet
FreeProduct Composition & Available Strengths
We supply Mefenamic Acid in standard, exact compendial strengths designed to support either acute, low-dose short-term relief or high-potency systemic anti-inflammatory regimens.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Mefenamic Acid IP / BP / USP 250 mg Oral Solid Film-Coated Tablet Acute Titration & Dysmenorrhea: Optimized for quick-onset dosing during the initialization of menstrual pain management or mild dental distress. Mefenamic Acid IP / BP / USP 500 mg Oral Solid Film-Coated Tablet High-Potency Stabilization: Standard international baseline strength for functional menorrhagia (heavy bleeding), osteoarthritis flare-ups, and severe acute musculoskeletal pain. Mefloquine Tablet
FreeProduct Composition & Configuration
We supply Mefloquine Hydrochloride in the internationally standardized strength calibrated for both adult therapeutic clearance and weekly travel prophylaxis.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Application Mefloquine Hydrochloride IP / BP / USP 250 mg
(Equivalent to 228 mg Mefloquine Base)
Oral Solid Uncoated Tablet (Cross-scored for exact pediatric dividing) Dual-Mode Antimalarial: High-dose 3-day treatment for active clearance, or low-dose once-weekly regimen for traveler chemoprophylaxis. Excipients Pharma Grade Microcrystalline Cellulose, Lactose, Magnesium Stearate The Disintegration Core: Engineered for uniform mechanical compression and rapid disintegration. Metformin Tablet
FreeProduct Composition & Portfolio Range
We manufacture Metformin SR in the full spectrum of internationally recognized therapeutic strengths, utilizing a specialized slow-release scaffold to reduce dosing frequency to once daily.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Metformin Hydrochloride IP / BP / USP 500 mg Hydrophilic Dual-Polymer Sustained-Release Initial Titration: For low-dose introductory management and early-stage Type 2 stabilization. Metformin Hydrochloride IP / BP / USP 750 mg Hydrophilic Dual-Polymer Sustained-Release Intermediate Scaling: Step-up strength to optimize glycemic indices without increasing tablet count. Metformin Hydrochloride IP / BP / USP 1000 mg Hydrophilic Dual-Polymer Sustained-Release High-Potency Maintenance: Maximizes daily therapeutic saturation in an elegant, once-daily single tablet format. Metformin Tablets
FreeProduct Composition & Available Specifications
We supply Metformin Hydrochloride across the full spectrum of compendial strengths and advanced kinetic delivery platforms to optimize patient compliance and reduce gastrointestinal side effects.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Metformin Hydrochloride USP / BP / IP 500 mg Oral Solid Immediate-Release Film-Coated Tablet Introductory Titration: Baseline format designed for low-dose introductory management and gradual step-up scaling. Metformin Hydrochloride USP / BP / IP 850 mg Oral Solid Immediate-Release Film-Coated Tablet High-Density Single Dose: Intermediate strength optimized for achieving target daily therapeutic thresholds with fewer tablets. Metformin Hydrochloride USP / BP / IP 1000 mg Oral High-Mass Immediate-Release Tablet Maximal Saturation Therapy: High-strength configuration calibrated for advanced glycemic control and high-dose combinations. Metformin Hydrochloride USP / BP / IP 500 mg / 1000 mg SR Extended/Sustained-Release Hydrophilic Polymer Matrix Premium GI-Comfort Compliance: Once-daily formulation utilizing a dual-layer hydrogel matrix to release active drug slowly, completely eliminating gastrointestinal distress. Methyl Cobalamin ,Vitamin B6 & Nicotinamide veterinary Injection
FreeCOMPOSITION
Methyl Cobalamin , Vitamin B6 & Nicotinamide INJ. 10 ML
Methyl Cobalamin , Vitamin B6 & Nicotinamide INJ. 30 ML
Methyl Cobalamin , Vitamin B6 & Nicotinamide INJ. 100 ML
Usage: – injections in veterinary medicine may be used to address specific conditions related to B3 deficiencies or skin disorders in animals.
Category: – injections in veterinary medicine
Therapeutic category: –injections in veterinary medicine
Methyl Ergonovine Maleate Tablet
FreeProduct Composition & Calibration Strength
We manufacture this critical emergency therapeutic in the globally accepted standard micro-dose strength optimized for postpartum routine oral management.
Active Ingredient Common Name Compendial Monograph Standard Strength Primary Clinical Target Methyl Ergonovine Maleate (Methylergometrine Maleate) USP / BP / IP 0.2 mg (200 mcg) The Uterotoner Matrix: Administered orally following initial IV/IM stabilization to maintain uterine tone and prevent bleeding recurrence. Excipients Pharma Grade Lactose, Starch, Povidone binders The Delivery Scaffold: Engineered for rapid physical disintegration and quick mucosal absorption. Methyldopa Tablet
FreeProduct Composition & Available Strengths
We supply Methyldopa in standard, exact strengths designed to facilitate the careful, progressive dose titration required in gestational healthcare.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Methyldopa Anhydrous IP / BP / USP 250 mg Oral Solid Film-Coated Tablet (Scored for micro-titration) Initial Titration / Baseline Care: For early-stage gestational hypertension and lower-dose fine-tuning. Methyldopa Anhydrous IP / BP / USP 500 mg Oral Solid Film-Coated Tablet (Engineered for uniform mass release) High-Potency Maintenance: For advanced chronic hypertension during pregnancy and severe pre-eclamptic stabilization. Methylprednisolone Tablet
FreeProduct Composition & Available Strengths
We supply Methylprednisolone in a comprehensive, internationally standardized range of strengths to facilitate both low-dose chronic maintenance and the high-dose taper packs mandatory in clinical steroid therapy.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Target Methylprednisolone USP / BP / IP 4 mg Oral Solid Uncoated Tablet (Cross-scored for micro-titration) Baseline Dose / Tapering: For rheumatoid arthritis maintenance and step-down dose regimens. Methylprednisolone USP / BP / IP 8 mg Oral Solid Uncoated Tablet (Cross-scored for micro-titration) Intermediate Management: For moderate asthma exacerbations and chronic dermatological conditions. Methylprednisolone USP / BP / IP 16 mg Oral Solid Uncoated Tablet (Cross-scored for flexible division) High-Potency Control: For acute autoimmune flares, immunosuppression in organ transplants, and oncology support. Metoclopramide Tablet
FreeProduct Composition & Packaging Specification
We supply Metoclopramide in the globally standardized therapeutic strength optimized for adult baseline three-times-daily dosage regimens.
Active Ingredient Monograph Calibrated Strength Formulation Delivery Matrix Primary Clinical Function Metoclopramide Hydrochloride USP / BP / IP 10 mg Oral Solid Uncoated Tablet (Scored for micro-dosing titration) The Prokinetic Driver: Accelerates upper gastrointestinal transit and blocks central emetic signals. Excipients Pharma Grade Lactose, Starch, Magnesium Stearate The Core Scaffold: High-solubility matrix engineered for rapid physical disintegration. Metoprolol Tablet
FreeCore Product Catalog:
Active Ingredient Monograph Standard Strengths Dosage Format Primary Clinical Target Metoprolol Tartrate IP/BP/USP 25 mg Immediate-Release Solid Tablet Acute Titration: For fine-tuned early adjustment in arrhythmias and mild hypertension. Metoprolol Tartrate IP/BP/USP 50 mg Immediate-Release Solid Tablet Standard Twice-Daily Blockade: Routine maintenance for Angina Pectoris and post-Myocardial Infarction stabilization. Metoprolol Tartrate IP/BP/USP 100 mg Immediate-Release Solid Tablet High-Threshold Control: For refractory tachyarrhythmias and intensive post-MI clinical management. Metronidazole Tablet
FreeProduct Composition & Available Strengths
We supply Metronidazole in standard, internationally recognized strengths optimized for adult and pediatric treatment regimens.
Active Ingredient Available Strengths Common Dosage Matrix Primary Clinical Target Metronidazole BP / IP / USP 200 mg Film-Coated / Uncoated Oral Tablet Pediatric & Low-Dose Titration: For delicate adjustments in mild amoebic dysentery or combination protocols. Metronidazole BP / IP / USP 400 mg Film-Coated / Uncoated Oral Tablet Standard Generic Backbone: Standard twice or thrice-daily dosing for dental abscesses and Giardiasis. Metronidazole BP / IP / USP 500 mg High-Potency Oral Tablet Institutional Target: High-volume strength preferred for anaerobic surgical prophylaxis and severe trichomoniasis. Misoprostol Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets, often hexagonal or scored, to allow for precise dosing. Due to the high potency of the API, we ensure rigorous content uniformity.
Active Ingredient Strength (Standard) Therapeutic Role Misoprostol BP/USP 200 mcg (0.2 mg) Prostaglandin E1 Analogue Excipients Q.S. Microcrystalline Cellulose / HPMC Stabilizing Dispersion Matrix Nalidixic Tablet
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets. The formulation is engineered for rapid disintegration to ensure the active ingredient is quickly processed for renal excretion.
Active Ingredient Strength (Standard) Therapeutic Role Nalidixic Acid BP/USP 500 mg Quinolone Antibacterial Excipients Q.S. Maize Starch / Gelatin Binder & Disintegrant Coating (Optional) Q.S. HPMC / Titanium Dioxide Film Coating Nelfinavir Tablet
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. Due to the high dose required for therapeutic efficacy, we ensure the tablet is engineered for ease of swallowing without compromising the structural integrity of the high-API load.
Active Ingredient Strength (Standard) Therapeutic Role Nelfinavir Mesylate USP/BP 250 mg Standard Adult / Pediatric Dose Nelfinavir Mesylate USP/BP 625 mg High-Strength Adult Maintenance Excipients Q.S. Calcium Silicate / Crospovidone Disintegrant & Stabilizer Nevirapine Tablet
FreeProduct Composition & Strengths
We supply this antiretroviral therapeutic in the globally accepted standard therapeutic strength optimized for adult combination maintenance therapy.
Active Ingredient Standard Strength Formulation Delivery Matrix Primary Clinical Function Nevirapine Anhydrous IP / BP / USP 200 mg Oral Solid Uncoated Tablet (Scored for flexible pediatric/titration dividing) The NNRTI Anchor: Suppresses viral replication loads when used in combination ARV regimens. Excipients Pharma Grade Lactose, Microcrystalline Cellulose, Sodium Starch Glycolate The Delivery Core: Ensures immediate physical disintegration and release kinetics. Nicoumalone Tablet
FreeProduct Composition & Calibration Spectrum
We manufacture Nicoumalone in a complete, highly precise range of strengths to allow for the exact dosage adjustments required to maintain narrow therapeutic targets.
Active Ingredient Common Name Compendial Monograph Available Strengths Primary Clinical Application Nicoumalone (Acenocoumarol) BP / IP / USP 1 mg Micro-Titration Phase: For delicate, low-dose fine-tuning in geriatric or sensitive patient profiles. Nicoumalone (Acenocoumarol) BP / IP / USP 2 mg Foundational Maintenance: The standard baseline dose for routine daily thromboembolic prophylaxis. Nicoumalone (Acenocoumarol) BP / IP / USP 3 mg Intermediate Control: For patients requiring step-up adjustment to hit targeted coagulation thresholds. Nicoumalone (Acenocoumarol) BP / IP / USP 4 mg High-Threshold Suppression: For rapid oral loading or patients presenting high chemical resistance to standard doses. Nifedipine Tablet
FreeProduct Composition & Structural Formats
We manufacture Nifedipine across the complete clinical dosage spectrum, utilizing distinct release matrices calibrated for immediate stabilization or sustained, once-daily therapeutic coverage.
Active Ingredient Available Strengths Formulation Matrix Delivery System Primary Clinical Focus Nifedipine IP/BP/USP 10 mg Immediate-Release / Rapid-Onset Film Tablet Acute Titration / Tocolysis: For severe acute hypertension or suppression of premature labor contractions. Nifedipine IP/BP/USP 20 mg Sustained-Release (SR) Retard Matrix Twice-Daily Maintenance: Intermediate control for stable chronic hypertension. Nifedipine IP/BP/USP 30 mg Once-Daily Extended-Release (XR / XL) Matrix First-Line Chronic Care: Continuous 24-hour plasma stabilization for mild-to-moderate hypertension. Nifedipine IP/BP/USP 60 mg Once-Daily Extended-Release (XR / XL) Matrix High-Potency Control: For refractory essential hypertension and severe chronic stable angina pectoris. Nifedipine Tablet
FreeProduct Composition & Structural Formats
We supply Nifedipine in exact, internationally standardized strengths, optimized for immediate-release emergency titration or controlled-release daily maintenance.
Active Ingredient Available Strengths Formulation Mechanism Primary Clinical Target Nifedipine IP / BP / USP 10 mg Immediate or Modified Release Acute Titration / Tocolysis: For rapid blood pressure adjustment or suppression of premature labor. Nifedipine IP / BP / USP 20 mg Sustained / Retard Matrix Daily Maintenance: Continuous 12-to-24-hour plasma concentration for chronic hypertension and angina. Nitroglycerin Tablet
FreeProduct Composition & Available Strengths
We supply Nitroglycerin Sublingual Tablets in exact, internationally calibrated low-dose strengths to allow for immediate rescue titration during acute ischemic episodes.
Active Ingredient Common Name Compendial Title Available Strengths Primary Clinical Target Nitroglycerin (GTN) Glyceryl Trinitrate IP / BP / USP 0.4 mg Standard Rescue Dose: Preferred international standard for immediate acute angina abortion. Nitroglycerin (GTN) Glyceryl Trinitrate IP / BP / USP 0.5 mg High-Threshold Prophylaxis: Calibrated for heavy coronary spasm management or pre-exertion protection. Norfloxacin Tablet
FreeProduct Composition & Strength
We supply Norfloxacin in the globally standardized therapeutic strength optimized for adult twice-daily dosage regimens.
Active Ingredient Strength (per Tablet) Primary Microbiological Function Norfloxacin USP / BP / IP 400 mg The DNA Gyrase Blocker: Eradicates susceptible urinary and gastrointestinal pathogens. Excipients Pharma Grade The Core Matrix: High-performance binders optimized for rapid tablet dissolution. Nystatin Tablet
FreeProduct Composition & Configuration
We supply this product in the internationally recognized standard therapeutic strength optimized for uniform, localized mucosal distribution.
Active Ingredient Strength (per Tablet) Formulation Delivery System Primary Clinical Function Nystatin IP / BP / USP 100,000 IU Non-Effervescent Local Insert: Designed for slow physical disintegration within vaginal mucosal fluids. The Polyene Fungicide: Eradicates superficial Candida strains locally. Excipients Pharma Grade Modified lactose, starch, and lubricating binding agents. The Comfort Base: Ensures non-irritating, smooth insertion profiles. Ofloxacin Tablets
FreeOfloxacin Tablets 200 mg
Each Filmcoated tablet contains :
Ofloxacin IP 200 mg
Excipients q.sYALLEY FLOX
Ofloxacin Tablets 200mg Each Film coated tablet contains :
Ofloxacin BP 200 mg
Excipients q.sOfnis -200
Ofloxacin Tablets
Each Filmcoated tablet contains :
Ofloxacin BP 200 mgUsage: – Treat bacterial infections
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Olanzepine Tablet
FreeProduct Composition & Available Strengths
We supply Olanzapine in standard, exact strengths to facilitate initial titration phases and safe daily maintenance therapy.
Active Ingredient Available Strengths Primary Clinical Target Olanzapine IP / BP / USP 2.5 mg Introductory Titration: For low-dose introductory cycles, elderly adjustment, or sensitive patient profiles. Olanzapine IP / BP / USP 5 mg Standard Maintenance: The baseline daily dosage for long-term schizophrenic and bipolar maintenance. Olanzapine IP / BP / USP 10 mg Acute Crisis Control: High-potency therapeutic dosing to stabilize acute manic or severe psychotic episodes. Ondansetron Orally Disintegrating Tablets
FreeProduct Composition & Available Formats
We supply Ondansetron ODT in the two primary compendial configurations required to support initial introductory pediatric dosing up to high-potency surgical and oncological maintenance regimens.
Active Ingredient Monograph Available Strengths Formulation Delivery Matrix Primary Clinical Application Ondansetron Base / Hydrochloride USP / BP / IP 4 mg Fast-Dispersing Hydrophilic Matrix (ODT) Pediatric & General Antiemetic: First-line baseline dosing for acute gastroenteritis, pediatric oncology protocols, and mild post-operative nausea. Ondansetron Base / Hydrochloride USP / BP / IP 8 mg Fast-Dispersing Hydrophilic Matrix (ODT) High-Potency Emetic Control: Advanced strength engineered for highly emetogenic chemotherapy cycles, abdominal radiation protocols, and immediate post-surgical recovery fields. Ondansetron Tablet
FreeProduct Composition & Available Strengths
We supply this critical supportive therapeutic in standard, internationally recognized strengths designed for exact preventative and rescue dosing.
Active Ingredient Available Strengths Primary Clinical Target Ondansetron HCl IP / BP / USP 4 mg Standard Prophylaxis: For moderate emetogenic chemotherapy, general post-operative rescue, and pediatric care. Ondansetron HCl IP / BP / USP 8 mg High-Potency Protection: For highly emetogenic cisplatin-based cancer regimens and severe surgical recovery. Oral Rehydration Salts (Sachets)
FreeProduct Composition & Osmolarity Calibration
We manufacture the exact Low-Osmolarity ORS configuration, which has been clinically proven to reduce stool volume, eliminate the need for intravenous infusions by greater than 33%, and physically shorten recovery windows compared to old high-osmolarity variants.
1. Powder Weight per Sachet (To Make 1 Litre of Solution)
Active Ingredient Mass per Sachet (Grams) Primary Physiological Function Glucose (Anhydrous) IP / BP / USP 13.50 g The Driver: Drives the active sodium transport mechanism. Sodium Chloride IP / BP / USP 2.60 g The Replenisher: Replaces lost extracellular fluid ions. Trisodium Citrate Dihydrate IP/BP/USP 2.90 g The Buffer: Corrects systemic metabolic acidosis. Potassium Chloride IP / BP / USP 1.50 g The Balancer: Prevents systemic hypokalemia. Total Weight 20.50 g Standard sachet yield for exactly 1000 mL of water. Oxcarbazepine Tablet
FreeProduct Composition & Available Strengths
We manufacture Oxcarbazepine in the full, internationally standardized range of strengths to allow for the precise, progressive dose titration mandatory in anti-epileptic therapy.
Active Ingredient Available Strengths Primary Clinical Target Oxcarbazepine IP / BP / USP 150 mg Pediatric & Initial Titration: For low-dose introductory phases to assess patient tolerance. Oxcarbazepine IP / BP / USP 300 mg Standard Maintenance: The foundational daily maintenance dose for adolescent and adult stabilization. Oxcarbazepine IP / BP / USP 600 mg High-Potency Control: For refractory focal seizures or high-threshold therapeutic stabilization. Pantoprazole Tablets
FreePantoprazole Tablets IP 40 mg
Each Enteric Coated tablet contains
Pantoprazole Sodium IP
Eq. To Pantoprazole 40 mgPenta-20
Pantoprazole Tablets 20 mg
Each Enteric Coated Tablet Contains
Pantoprazole Sodium Sesquihydrate
Eq To Pantoprazole 20 mgPenta – 40
Pantoprazole Tablets 40 mg
Each Entreric Coated tablet contains
Pantoprazole Sodium Sesquihydrate
Eq. To pantoprazole 40 mgUsage: – Heartburn, acid reflux and gastro-esophageal reflux disease
Category: – Antacid & Anti ulcer drugs
Therapeutic category: – Antiulcer, Antacid
Paracetamol Caffeine Chlorpheniramine Maleate Phenylephrine Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) optimized for maximum clinical efficacy.
Active Ingredient Strength (per Tablet) Primary Clinical Function Paracetamol (Acetaminophen) 325 mg / 500 mg The Pain & Fever Reliever: Targets aches and chills. Caffeine (Anhydrous) 30 mg The Potentiator: Boosts pain relief and alertness. Chlorpheniramine Maleate 2 mg / 4 mg The Antiallergic: Stops sneezing and runny nose. Phenylephrine HCl 5 mg / 10 mg The Decongestant: Clears blocked sinuses. Paracetamol, Diclofenac Sodium & Caffeine Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) designed for maximum therapeutic synergy.
Pentoxifylline Tablets
FreePentoxifylline Tablets 400 mg
Each Filmcoated tablet contains :
Pentoxifylline BP 400 mgUsage: – To reduce leg pain caused by poor blood circulation
Category: – Anti Cardiovascular drugs
Therapeutic category: – Cardiovascular
Pheniramine Maleate Tablets
FreePheniramine Maleate Tablets IP 25 mg
Each Uncoated Tablet Contains :
Pheniramine Maleate IP 25 mgPhenobarbital Tablets
FreePhenobarbitone Tablets IP
Each Uncoated tablet contains :
Phenobarbitone IP 30 mg
Excipients q.sPhenobarbitone Tablets IP 60 mg
Phenobarbital Tablets IP 60 mg
Each Uncoated tablet contains :
Phenobarbitone IP 60 mg
Phenobarbital
Excipients q.sPhenobarbital Tablets BP
Each Uncoated tablet contains :
Phenobarbital BP 30 mgPhenobarbital Tablets BP 60 mg
Each Uncoated tablet contains :
Phenobarbital BP 60 mg Excipients q.sPHENOBARBITAL TABLETS BP 90 MG Each Uncoated tablet contains : Phenobarbital BP 90 mg
Excioients 0 QSPhenobarbital Tablets BP 100 mg
Each Uncoated tablet contains :
Phenobarbital BP 100 mg Excipients -QSUsage: – To control seizures
Category: – Anti Hypertensive / Cardiac Drugs
Therapeutic category: – Hypertensive
Pyridoxine Tablets
FreePyridoxine Hydrochloride Tablets IP
Eac Uncoated tablet contains :
Pyridoxine Hydrochloride IP 25 mgPyridoxine Tablets IP 50 mg
Each Uncoated tablet contains:
Pyridoxine Hydrochoride IP 50 mgPyridoxine Tablets IP 100 mg
Each Uncoated tablet contains:
Pyridoxine Hydrochoride IP 100 mgPyridoxine Tablets BP 25 mg
Eac Uncoated tablet contains :
Pyridoxine Hydrochloride BP 25 mgUsage: – Prevent or treat a certain nerve disorder
Category: – Vitamin supplement
Therapeutic category: – Vitamin supplement
Rifampicin & Isoniazid Tablets
FreeProduct Composition & Standard Compendial Configurations
We supply this FDC in the internationally recognized, World Health Organization (WHO) recommended dosage strengths calibrated to support exact adult and pediatric weight-band categories.
Active Ingredients Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Rifampicin + Isoniazid BP/USP/IP 150 mg + 75 mg Oral Solid Film-Coated Tablet Adult Continuation Phase: Standard international baseline configuration utilized daily for the 4-month consolidation phase of pulmonary tuberculosis. Rifampicin + Isoniazid BP/USP/IP 300 mg + 150 mg Oral High-Mass Film-Coated Tablet High-Weight Adult Maintenance: High-potency format optimized to ensure single-tablet compliance for patients in higher weight bands. Rifampicin + Isoniazid BP/USP/IP 60 mg + 30 mg / 60 mg + 60 mg Oral Solid Soluble / Dispersible Tablet Pediatric Regimen Management: Fruit-flavored, water-soluble dispersible matrices engineered for exact dose compliance in pediatric networks. Rifampicin Isoniazide Pyrizinamide Tablets
FreeRifampicin, Isoniazide and Pyrizinamide Tab (Combi Pack)
(Rifampicin Tablets IP) + (Isoniazide Tablets IP) + (Pyrizinamide Tablets IP)
Each film Coated Tablet Contains :
Rifampicin IP 100 mg
Each coated Tablet Contains :
Isonoazide IP 50 mg
Each coated Tablet contains :
Pyrizinamide IP 250 mgRIP TABLETS
(Rifampicin, Isoniazid And Pyrazinamide Tablets Int.Ph.)
Each Filmcoated Tablet Contains:
Rifampicin BP/Int.Ph. 150 mg
Isoniazid BP/Int.Ph. 75 mg
Pyrazinamide BP/Int.Ph. 400 mgUsage: – treat tuberculosis (TB) infection
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic, Antituberculosis
Rifampicin, Isoniazid, Pyrazinamide & Ethambutol Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (usually Brown or Reddish-Brown). We offer both the “Daily Regimen” and “Intermittent Regimen” strengths.
Active Ingredient Strength (WHO Daily FDC) Therapeutic Role Rifampicin IP/BP/USP 150 mg Sterilizing / Broad Spectrum Isoniazid IP/BP/USP 75 mg Early Bactericidal Pyrazinamide IP/BP/USP 400 mg Intracellular Sterilizing Ethambutol HCl IP/BP/USP 275 mg Resistance Prevention Risperidone Tablets
FreeRisperidone Tablets 1 mg
Each film coated tablet contains:
Risperidone IP 1 mgRisperidone Tablets 2 mg
Each film coated tablet contains:
Risperidone IP 2 mgRisperidone Tablets 3 mg
Each film coated tablet contains:
Risperidone IP 3 mgRisperidone Tablets 4 mg
Each film coated tablet contains:
Risperidone IP 4 mgRisperidone Tablets 1 mg
Each film coated tablet contains:
Risperidone BP 1 mgRisperidone Tablets 2 mg
Each film coated tablet contains:
Risperidone BP 2 mgRisperidone Tablets 3 mg
Each film coated tablet contains:
Risperidone BP 3 mgRisperidone Tablets 4 mg
Each film coated tablet contains:
Risperidone BP 4 mgUsage: – treat certain mental/mood disorders
Category: – Anti Anxiety drugs
Therapeutic category: – Antipsychotic, Antidepressant, CNS Drugs, Anti Anxiety
Rosuvastatin Tablets
FreeRucol
Rosuvastatin Tablets 10 mg
Each Film Coated Tablet Contains:
Rosuvastatin Calcium
eq. To Rosuvastatin 10 mgUsage: – treat certain mental/mood disorders
Category: – Anti Cardiovascular drugs
Therapeutic category: – Antilipidemic, Cardiovascular Agent
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Roxithromycin Tablets
FreeRoxiron-150
(Roxithromycin tablets 150 mg)
Each Film coated tablets contains:
Roxithromycin BP 150 mgUsage: – treats bacterial infections
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Secnidazole Tablets
FreeSecnidazole Tablets IP 500 mg
Each Filmcoated tablet contains :
Secnidazole IP 500 mgSecnidazole Tablets I.P.
Each Filmcoated tablet contains :
Secnidazole IP 1 gmSeczole -2 Secnidazole Tablets IP 2 gm
Each film coated tablet contains:
Secnidazole IP 2 gmUsage: – treat vaginal infection (vaginosis) caused by bacteria
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Serratiopeptidase Tablets
FreeSERRATIOPTIDASE TABLETS 5 MG
Enteric Coated Tablet:
Serratiopeptidase 10000 Serratiopeptidase unit 5 MG
Usage: – back pain, osteoarthritis, rheumatoid arthritis, osteoporosis, fibromyalgia, carpel tunnel syndrome, migraine headache, and tension headache
Category: – Anti-inflammatory drug (NSAIDs)
Therapeutic category: – Anti-inflammatory
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Sertraline Tablets
FreeSertraline Tablet IP 50 mg
Each Filmcoated Tablet Contains:
Sertraline Hydrochloride
eq. To Sertraline 50 mgUsage: – Treat depression
Category: – Anti Anxiety drugs
Therapeutic category: – Antipsychotic, Antidepressant, CNS Drugs, Anti Anxiety
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Sodium Feredetate Folic acid Vitamin B12 Tablets
FreeSodium Feredetate, Folic Acid & Vitamin B12 Tablets
Each Film coated Tablet contains:
Sodium Feredetate BP 231 mg (equivalent to 33 mg elemental Iron)
Folic Acid BP 1.5 mg
Vitamin B12 BP 15 mgUsage: – treat or prevent vitamin deficiency before, during, and after pregnancy
Category: – Vitamin Supplement
Therapeutic category: – Vitamin Supplement
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Spironolactone Tablets
FreeSpironolactone Tablets IP 25 mg
Each Filmcoated tablet contains :
Spironolactone IP 25 mgSpironolactone Tablets IP
Each Film Coated Contanis:
Spironolactone IP 50 mgUsage: – high blood pressure and heart failure
Category: – Diuretic Drugs
Therapeutic category: – Diuretic
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Sulfadoxine Pyrimethamine Tablets
FreeGomaxine
Sulfadoxine and Pyrimethamine tablets USP
Each Uncoated tablet contains :
Sulfadoxine USP 500 mg
Pyrimethamine USP 25 mgSULPHADOXINE 7 PYRIMETHAMINE TABLETS IP Each uncoated tablet contains: Sulphadoxine IP 125 mg Pyrimethamine IP 6.25 mg Excipients q.s.
Usage: – treat malaria
Category: – Antimalarial drugs
Therapeutic category: – Antimalarial
Sulphadiazine Tablets
FreeSulphadiazine Tablets IP
Each Uncoated Tablets Contains:
Sulphadiazine IP 500 mgUsage: – urinary tract infections
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic
Tacrolimus Tablets
FreeTacrolimus Tablets 1 MG film coated tablet: Anhydrous Tacrolimus 1 MG
Usage: – to prevent rejection of a kidney, heart, or liver transplant
Category: – Generic drugs & Medicine
Therapeutic category: – Generic
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Tenofovir Tablets
FreeAbivir
Tenofovir Disoproxil Fumarate Tablet 300 mg
Each Film Coated Tablet Contains:
Tenofovir Disoproxil Fumarate 300 mgUsage: – help control HIV infection
Category: – HIV Anti viral drugs
Therapeutic category: – Antiviral, Anti HIV
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Theophyline Tablet
FreeTheophyline Tablets 200 mg
Each Uncoated tablet contains :
Theophyline IP 200 mUsage: – Prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma
Category: – Anti Allergic Drugs
Therapeutic category: – Antiasthmatic, Antitussive, Bronchodilator
Tinidazole Tablet
FreeTinidazole Tablets
Each Filmcoated tablet contains :
Tinidazole BP 500 mgUsage: – treat infections caused by protozoa
Category: – Antibiotic drugs
Therapeutic category: – Antibiotic, Anthelmintic, Antiprotozoal, Antiparasitic
Tranexamic Tablet
FreeProduct Composition & Strength
We supply this product in film-coated tablets for oral administration.
Active Ingredient Strength Form Tranexamic Acid BP/USP 250 mg Film Coated Tablet Tranexamic Acid BP/USP 500 mg Film Coated Tablet Zidovudine Tablet
FreeProduct Composition & Strength
We supply this product in standardized strengths optimized for both monotherapy (in specific PMTCT cases) and combination therapy (HAART).
Active Ingredient Strength Primary Clinical Target Zidovudine IP/BP/USP 300 mg The Foundation: Standard dose for adult HIV management. Excipients Pharma Grade The Matrix: Ensures shelf-life stability and rapid absorption. Zinc Dispersible Tablet
FreeProduct Composition & Strength
We supply this product as Dispersible Tablets (DT), specifically engineered for pediatric ease of use where swallowing whole pills is not possible.
Active Ingredient Strength (Elemental Zinc) Primary Clinical Function Zinc Sulphate Monohydrate 20 mg The Gut Restorer: Essential for diarrhea recovery. Excipients Pharma Grade The Dispersant: Ensures tablet dissolves in seconds. Flavoring Orange / Vanilla / Pineapple The Palatable Base: Ensures pediatric compliance.
